[Predominant central vestibular symptomatology caused by carbamazepine and dextropropoxyphene interaction].
Bertholon
P
P
Convers
P
P
Lachheb
N
N
Guy
C
C
Martin
C
C
Ollagnier
M
M
Michel
D
D
D000328:Adult; D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects*; D000701:Analgesics, Opioid / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects*; D011431:Dextropropoxyphene / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015837:Vestibular Diseases / Q000139:chemically induced*
D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D002220:Carbamazepine; D011431:Dextropropoxyphene
Sémiologie vestibulaire centrale prépondérante par interaction carbamazépine et dextropropoxyphène.